Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
712
datasets available to search
ShareScore release 0.9.0
Dataset results
712 results for “mantle”
Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL)
ClinicalTrials.gov study NCT03616782. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01729104. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy
ClinicalTrials.gov study NCT07341191. IPD Sharing: YES. Countries: 0. Publications: 0.
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)
ClinicalTrials.gov study NCT00407303. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT06341556. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease
ClinicalTrials.gov study NCT07272499. IPD Sharing: NO. Countries: 1. Publications: 0.
Zanubrutinib-based Induction and Maintenance Therapy in Young and Fit Patients With Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04736914. IPD Sharing: NO. Countries: 1. Publications: 0.
Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT06675123. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Mantle Cell Lymphoma Treatment by RiBVD
ClinicalTrials.gov study NCT01457144. IPD Sharing: NO. Countries: 1. Publications: 0.
Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03617484. IPD Sharing: NO. Countries: 1. Publications: 0.
Acalabrutinib Plus Rituximab for the Treatment of Elderly or Low- to Intermediate-Risk Younger Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT06846489. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Obinutuzumab, Zanubrutinib, and Lenalidomide in First-line Treatment of Mantle Cell Lymphoma
ClinicalTrials.gov study NCT07261163. IPD Sharing: NO. Countries: 1. Publications: 0.
TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
ClinicalTrials.gov study NCT06106841. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Parsaclisib, a PI3Kδ Inhibitor, in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04849715. IPD Sharing: YES. Countries: 0. Publications: 0.
A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05506410. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT06253663. IPD Sharing: NO. Countries: 1. Publications: 0.
Ketogenic Diet in Patients With Untreated Low Tumor Burden Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04231734. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma
ClinicalTrials.gov study NCT01148108. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00058227. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma
ClinicalTrials.gov study NCT07207785. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.